Kbc Group Nv Myriad Genetics Inc Transaction History

Kbc Group Nv

$33.1 Billion
Q2 2024

A detailed history of Kbc Group Nv transactions in Myriad Genetics Inc stock. As of the latest transaction made, Kbc Group Nv holds 2,511 shares of MYGN stock, worth $55,141. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,511

Previous 2,511 -0.0%

Holding current value

$55,141

Previous $54,000 12.96%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$13.91 - $21.32 $53,470 - $81,954	-3,844 Reduced 60.49%	2,511 $48,000
Q3 2023 Feb 15, 2024	SELL	$15.99 - $23.22 $61,465 - $89,257	-3,844 Reduced 60.49%	2,511 $40,000
Q2 2023 Feb 15, 2024	SELL	$17.56 - $23.76 $11,027 - $14,921	-628 Reduced 8.99%	6,355 $147,000
Q1 2023 Feb 14, 2024	SELL	$15.26 - $23.75 $9,583 - $14,915	-628 Reduced 8.99%	6,355 $148,000
Q1 2023 May 04, 2023	SELL	$15.26 - $23.75 $9,583 - $14,915	-628 Reduced 8.99%	6,355 $148,000
Q3 2022 Feb 15, 2024	BUY	$18.21 - $27.88 $81,435 - $124,679	4,472 Added 178.1%	6,983 $133,000
Q2 2022 Feb 14, 2024	BUY	$16.45 - $25.88 $95,903 - $150,880	5,830 Added 505.64%	6,983 $127,000
Q2 2022 Jul 26, 2022	BUY	$16.45 - $25.88 $114,870 - $180,720	6,983 New	6,983 $127,000
Q1 2022 May 06, 2022	SELL	$22.67 - $28.01 $26,138 - $32,295	-1,153 Closed	0 $0
Q4 2021 Feb 14, 2024	SELL	$24.13 - $32.63 $32,768 - $44,311	-1,358 Reduced 54.08%	1,153 $32,000
Q3 2021 Nov 10, 2021	SELL	$29.97 - $36.66 $436,033 - $533,366	-14,549 Reduced 92.66%	1,153 $37,000
Q2 2021 Aug 11, 2021	BUY	$25.39 - $32.61 $77,337 - $99,330	3,046 Added 24.07%	15,702 $480,000
Q4 2020 Feb 10, 2021	SELL	$12.16 - $19.77 $24,271 - $39,460	-1,996 Reduced 13.62%	12,656 $250,000
Q3 2020 Oct 28, 2020	SELL	$11.25 - $14.75 $46,091 - $60,430	-4,097 Reduced 21.85%	14,652 $191,000
Q2 2020 Aug 10, 2020	SELL	$10.69 - $16.49 $264,417 - $407,880	-24,735 Reduced 56.88%	18,749 $213,000
Q1 2020 May 04, 2020	BUY	$9.78 - $29.53 $110,709 - $334,279	11,320 Added 35.19%	43,484 $622,000
Q1 2019 May 10, 2019	BUY	$26.93 - $34.7 $463,438 - $597,152	17,209 Added 115.07%	32,164 $0
Q4 2018 Jan 31, 2019	SELL	$27.23 - $45.56 $756,013 - $1.26 Million	-27,764 Reduced 64.99%	14,955 $434,000
Q3 2018 Nov 14, 2018	BUY	$37.57 - $50.34 $1.18 Million - $1.59 Million	31,532 Added 281.86%	42,719 $0
Q2 2018 Aug 03, 2018	SELL	$27.75 - $40.17 $99,428 - $143,929	-3,583 Reduced 24.26%	11,187 $0
Q1 2018 May 09, 2018	BUY	$28.83 - $41.01 $218,444 - $310,732	7,577 Added 105.34%	14,770 $0
Q4 2017 Feb 07, 2018	BUY	$28.45 - $37.14 $55,818 - $72,868	1,962 Added 37.51%	7,193 $0
Q3 2017 Nov 13, 2017	BUY	$24.01 - $36.2 $125,596 - $189,362	5,231	5,231 $0

Others Institutions Holding MYGN

# of Institutions

237

Shares Held

92.7M

Call Options Held

117K

Put Options Held

113K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.77B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account